Clinical Trial Update: Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether positron emission tomography (PET) can predict response in stage I-III non-small cell lung cancer patients treated with pemetre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Pemetrexed disodium (Alimta) (pemetrexed disodium)

Snippet

Sponsor: University of Washington | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-04